CENTER OF MOLECULAR IMMUNOLOGY

Trials shown by sponsor

Public title	Date of Registration	State
Nimotuzumab in COVID-19	21/05/2021	Registered
CIMAvax-EGF/Lung cancer/Biomarkers/Prospective CT	20/10/2021	Registered
NeuroEPO in mild-moderate Alzheimer's disease	20/09/2022	Registered
NeuroEPO in mild-moderate Alzheimer's disease amnesic variant	22/09/2022	Registered
Her1 vaccine in metastatic colon and prostate cancer	16/08/2023	Registered
CIMAvax-EGF vaccine Predictor Phase IV	14/12/2015	Registered outdated
Treatment of SARS CoV-2 pneumonia with the anti-CD6 monoclonal antibody itolizumab	12/05/2020	Registered outdated
NGcGM3/VSSP in small cell lung cancer	07/12/2016	Registered outdated
RituxCIM in relapsed or refractory indolent B-cell non-Hodgkin lymphoma	05/11/2013	Registered outdated
Vaxira as adjuvant treatment for non-small cell lung cancer	15/12/2015	Registered outdated
Dose scale-up and cohort expansion with the therapeutic mAb 14F7	04/12/2015	Registered outdated
1B8 vs MabThera® in patients with Diffuse large B-cell lymphoma	01/09/2016	Registered outdated
Phase I/II trial with the mutein no alfa of IL-2	03/02/2017	Registered outdated
Nimotuzumab in Non-Small Cell Lung Cancer (NSCLC) of inoperable stage III epidermoid histology, concomitant with Chemo and Radiotherapy (CRT)	28/12/2018	Registered outdated
CIMAvax-EGF in patients at high risk of lung cancer	22/10/2020	Registered outdated
CIMAvax-EGF in Bladder cancer	11/08/2020	Registered outdated
Safety and efficacy of VAXIRA® in advanced NSCLC patients not progressing after first line chemotherapy. Phase III.	01/10/2020	Registered outdated
NeuroEPO-Ataxia-Adults-Phase III	19/11/2020	Registered outdated
Phyisician Led CIMAvax-EGF lung biomarkers	11/03/2021	Registered outdated
Biomodulina T- CIMAvax-EGF-Advanced Non-Small Cell Lung Cancer-Adults	18/03/2021	Registered outdated

Registered Trials

Registration process

CENTER OF MOLECULAR IMMUNOLOGY

About the RPCEC

Useful resources